Lantern Production Line Two

Fixed-rate notes on medical isotope production. No reactor, no fuel, and a customer base that cannot substitute.

Molybdenum-99 decays into the technetium-99m used in roughly forty million diagnostic scans a year, and it has historically come from a handful of aging research reactors, two of which have gone offline unexpectedly and caused global shortages. Accelerator production needs no reactor and no fissile fuel, and its output has a 66-hour half-life, which means the product cannot be stockpiled and customers cannot switch suppliers on short notice. Line one is in commercial operation; this funds line two.

Tri-Valley Isotope Facility · Livermore, CAOperating license issuedEscrow: Meridian Trust, N.A.

TRL 8 of 9, band 7.7 to 8.4, signed by Dr. Samuel Adeyemi, PhD Nuclear Engineering; ASME Section III reviewer, on May 10, 2026.See the evidence it rests on

$12,240,000 committed of $18,000,000

$11,016,000 released · 68% subscribed

Released to the issuerCommitted, held in escrowRemaining

Minimum: $500
Target coupon: 6.15%
Term: 6 yr
Investors: 2,483

Closes February 26, 2027 · 166 days remaining

Eligibility depends on residency, accreditation status and how much you have already invested this year.
You can read everything about this offering without an account. Committing capital requires one.

Open an account

Open an account to invest

Demo · viewing as

Browsing without an account. Everything is visible; nothing is purchasable until you verify who and where you are.

Or answer the questions yourself

No money will move

No payment processor is connected. The commitment flow runs end to end, through amount, agreement, signature and receipt, and records a simulated position rather than a charge.

Principal risks of this offering

A 66-hour half-life means any production interruption is an immediate revenue loss with no inventory to draw on.
Reimbursement rates for diagnostic imaging are set by payers and can be reduced.
New reactor-based and accelerator-based supply entering the market could compress pricing.
Accelerator availability is the single point of failure until line two is commissioned.

General risks of private securities

Private securities are speculative and illiquid. You should be prepared to hold this position for its full term and to lose the entire amount invested. Nuclear construction has a documented history of schedule and cost overrun. Platforms that sold equity in unbuilt energy projects have mostly failed; those that sold debt against operating assets with contracted offtake have mostly survived. That history is why the TRL tier of an offering matters more than its headline return.

A TRL score is not a prediction and not a rating. Read the offering documents in full before committing capital.